We aimed to study the renal injury and hypertension induced by chronic intermittent
hypoxia (CIH) and the protective effects mediated by angiotensin 1-7 [Ang(1-7)]. We
randomly assigned 32 male Sprague-Dawley rats (body weight 180-200 g) to normoxia
control, CIH, Ang(1-7)-treated normoxia, and Ang(1-7)-treated CIH groups. Systolic
blood pressure (SBP) was monitored at the start and end of each week. Renal
sympathetic nerve activity (RSNA) was recorded. CTGF and TGF-β were detected by
immunohistochemistry and western blotting. Tissue parameters of oxidative stress were
also determined. In addition, renal levels of interleukin-6, tumor necrosis factor-α,
nitrotyrosine, and hypoxia-inducible factor-1α were determined by
immunohistochemistry, immunoblotting, and ELISA. TUNEL assay results and cleaved
caspase 3 and 12 were also determined. Ang(1-7) induced a reduction in SBP together
with a restoration of RSNA in the rat model of CIH. Ang(1-7) treatment also
suppressed the production of reactive oxygen species, reduced renal tissue
inflammation, ameliorated mesangial expansion, and decreased renal fibrosis. Thus,
Ang(1-7) treatment exerted renoprotective effects on CIH-induced renal injury and was
associated with a reduction of oxidative stress, inflammation and fibrosis. Ang(1-7)
might therefore represent a promising therapy for obstructive sleep apnea-related
hypertension and renal injury.